Bharat Biotech seeks DCGI's permission to conduct Covaxin booster trials in the 2-18 age group
December 3, 2023
  • Circulation
  • Advertise
  • Careers
  • About Us
  • Contact Us
Organiser
  • ‌
  • Bharat
    • Assam
    • Bihar
    • Chhattisgarh
    • Jharkhand
    • Maharashtra
    • View All States
  • World
    • Asia
    • Europe
    • North America
    • South America
    • Africa
    • Australia
    • Global Commons
  • Editorial
  • Analysis
  • Opinion
  • International
  • More
    • G20
    • Sports
    • Defence
    • RSS in News
    • Azadi Ka Amrit Mahotsav
    • Politics
    • Vocal4Local
    • Business
    • Economy
    • Special Report
    • Culture
    • Sci & Tech
    • Entertainment
    • Education
    • Books
    • Interviews
    • Travel
    • Law
    • Health
    • Obituary
    • Podcast
MAGAZINE
No Result
View All Result
  • ‌
  • Bharat
    • Assam
    • Bihar
    • Chhattisgarh
    • Jharkhand
    • Maharashtra
    • View All States
  • World
    • Asia
    • Europe
    • North America
    • South America
    • Africa
    • Australia
    • Global Commons
  • Editorial
  • Analysis
  • Opinion
  • International
  • More
    • G20
    • Sports
    • Defence
    • RSS in News
    • Azadi Ka Amrit Mahotsav
    • Politics
    • Vocal4Local
    • Business
    • Economy
    • Special Report
    • Culture
    • Sci & Tech
    • Entertainment
    • Education
    • Books
    • Interviews
    • Travel
    • Law
    • Health
    • Obituary
    • Podcast
No Result
View All Result
Organiser
No Result
View All Result
  • Home
  • Bharat
  • World
  • G20
  • Editorial
  • Opinion
  • Analysis
  • Culture
  • Defence
  • International Edition
  • RSS in News
  • Magazine
Home Bharat

Bharat Biotech seeks DCGI’s permission to conduct Covaxin booster trials in the 2-18 age group

The company applied for permission a week ago. It has already conducted trials in the age group of 2-18 for two doses of Covaxin.

by Shalini Bhardwaj
May 4, 2022, 05:12 pm IST
in Bharat
COVAXIN

COVAXIN

FacebookTwitterWhatsAppTelegramEmail

New Delhi [India], May 4 (ANI): Hyderabad-based pharma company Bharat Biotech has sought permission from the Drugs Controller General of India (DCGI) to conduct trials of Covaxin as a COVID-19 vaccine booster dose in the 2-18 age group, sources said.

The company applied for permission a week ago. It has already conducted trials in the age group of 2-18 for two doses of Covaxin.

Recently, Bharat Biotech has also received an Emergency Use Authorisation (EUA) approval for 6-12 years old children for two doses.

Bharat Biotech has also applied for the EUA for the 2-5 years old, but Subject Expert Committee (SEC) has asked for more data.

Bharat Biotech is the first company in India who had applied for permission from DCGI to conduct trials of a booster dose in the 2-18 age group.

Currently, the Covaxin is under the national COVID vaccination programme for the above 15-18 age group for two doses and above 18 years old for a precaution dose.

The trials for Bharat Biotech’s intranasal booster on a heterologous group are under trial, according to the sources data collection process is over for the age group above 18 years. (ANI)

Topics: COVAXINBharat BiotechCOVID-19 vaccineDGCIDrugs Controller General of India (DCGI)Drugs Controller General of India
Share16TweetSendShareSend
Previous News

Centre gives nod for diversion of forest land for rapid development in Naxal-affected states

Next News

Prime Minister Narendra Modi participates in India-Nordic Summit in Copenhagen

Related News

Bharat Biotech forge strategic partnership with University of Sydney for vaccine research

Bharat Biotech forge strategic partnership with University of Sydney for vaccine research

The Vaccine War: Movie on how India fought against coronavirus; salute to COVID warriors

The Vaccine War: Movie on how India fought against coronavirus; salute to COVID warriors

On Republic Day, Bharat Biotech launches first India-made nasal Covid Vaccine

On Republic Day, Bharat Biotech launches first India-made nasal Covid Vaccine

Fake News: Govt rejects fake news reports that regulatory approval for Covaxin rushed due to Political Pressure

Fake News: Govt rejects fake news reports that regulatory approval for Covaxin rushed due to Political Pressure

Clinical phase III trials of the Bharat Biotech’s COVID-19 nasal vaccine completed

Clinical phase III trials of the Bharat Biotech’s COVID-19 nasal vaccine completed

Japan recognises India’s COVAXIN to facilitate travel between both countries

Covaxin safe for children aged 2-18 years, says Bharat Biotech

Load More

Comments

The comments posted here/below/in the given space are not on behalf of Organiser. The person posting the comment will be in sole ownership of its responsibility. According to the central government's IT rules, obscene or offensive statement made against a person, religion, community or nation is a punishable offense, and legal action would be taken against people who indulge in such activities.

Latest News

Thinking aloud Bhopal holocaust and the BP oil explosion

Thinking aloud Bhopal holocaust and the BP oil explosion

Common headaches linked to neck inflammation: Research

Common headaches linked to neck inflammation: Research

Cooperative Sector joins developed India Sankalp Yatra, vows to make Bharat fully developed in Amrit Kaal: Tomar

Cooperative Sector joins developed India Sankalp Yatra, vows to make Bharat fully developed in Amrit Kaal: Tomar

Pakistan: Imran Khan’s Tehreek-e-Insaaf to hold intra-party elections under umbrella of Election Commission

Pakistan: Imran Khan’s Tehreek-e-Insaaf to hold intra-party elections under umbrella of Election Commission

Uttar Pradesh: Fake Covid vaccine certificates racket exposed; Mohammad Zubair, Sahil and Riyazuddin arrested by STF

Uttar Pradesh: Fake Covid vaccine certificates racket exposed; Mohammad Zubair, Sahil and Riyazuddin arrested by STF

Tamil Nadu BJP President K Annamalai questions CM Stalin’s flip-flop on CBI probe into illegal sand mining

Tamil Nadu BJP President K Annamalai questions CM Stalin’s flip-flop on CBI probe into illegal sand mining

Tamil Nadu: Madras High Court dismisses DMK MP Jagathrakshakan’s petition challenging ED proceedings under FEMA Act

Tamil Nadu: Madras High Court dismisses DMK MP Jagathrakshakan’s petition challenging ED proceedings under FEMA Act

Bhumi Pooja held for the construction of Dr Hedgewar Smriti Mandir at Kandukurti, ancestral village of RSS founder

Bhumi Pooja held for the construction of Dr Hedgewar Smriti Mandir at Kandukurti, ancestral village of RSS founder

Nagaland: US Ambassador Eric Garcetti mesmerised by Hornbill Festival experience in Kohima

Nagaland: US Ambassador Eric Garcetti mesmerised by Hornbill Festival experience in Kohima

Tamil Nadu: HR & CE department grants permission for consecration of Kari Varadaraja Perumal Temple amidst controversy

Tamil Nadu: HR & CE department grants permission for consecration of Kari Varadaraja Perumal Temple amidst controversy

  • Privacy
  • Terms
  • Cookie Policy
  • Refund and Cancellation
  • Delivery and Shipping

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies

No Result
View All Result
  • Home
  • Bharat
    • Assam
    • Bihar
    • Chhattisgarh
    • Jharkhand
    • Maharashtra
    • View All States
  • World
    • Asia
    • Africa
    • North America
    • South America
    • Europe
    • Australia
    • Global Commons
  • Editorial
  • Opinion
  • Analysis
  • Defence
  • Culture
  • Sports
  • Business
  • RSS in News
  • Entertainment
  • More ..
    • Sci & Tech
    • Vocal4Local
    • Special Report
    • Education
    • Books
    • Interviews
    • Travel
    • Health
    • Politics
    • Law
    • Economy
    • Obituary
    • Podcast
  • Subscribe Magazine
  • Advertise
  • Circulation
  • Careers
  • About Us
  • Contact Us
  • Policies & Terms
    • Privacy Policy
    • Cookie Policy
    • Refund and Cancellation
    • Terms of Use

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies